Page last updated: 2024-08-23

bromocriptine and tolcapone

bromocriptine has been researched along with tolcapone in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (16.67)18.2507
2000's3 (25.00)29.6817
2010's5 (41.67)24.3611
2020's2 (16.67)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chang, G; Di, L; Huang, Y; Lin, Z; Liston, TE; Scott, DO; Troutman, MD; Umland, JP1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Chellappan, DK; Collet, TA; Dighe, SN; Dua, K; Ekwudu, O; Katavic, PL1
Agid, Y; Destée, A; Durif, F; Montastruc, JL; Pollak, P1
Clarke, CE; Deane, KH; Spieker, S1
Goetz, CG; Poewe, W; Rascol, O; Sampaio, C1
Al-Zughoul, A; Cameron, IGM; D'Esposito, M; Kayser, AS; Wallace, DL1
D'Esposito, M; Furman, DJ; Kayser, A; Naskolnakorn, J; White, RL; Ye, J1
D'Esposito, M; Furman, DJ; Kayser, AS; Pappas, I; White, RL1

Reviews

5 review(s) available for bromocriptine and tolcapone

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Recent update on anti-dengue drug discovery.
    European journal of medicinal chemistry, 2019, Aug-15, Volume: 176

    Topics: Animals; Antiviral Agents; Biological Products; Cell Line, Tumor; Dengue Virus; Drug Discovery; Humans; Serine Proteinase Inhibitors; Viral Nonstructural Proteins; Virus Replication

2019
DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17 Suppl 4

    Topics: Benzophenones; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Therapy, Combination; Enzyme Inhibitors; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Nitrophenols; Parkinson Disease; Pergolide; Randomized Controlled Trials as Topic; Tolcapone

2002
Catechol-O-methyltransferase inhibitors versus active comparators for levodopa-induced complications in Parkinson's disease.
    The Cochrane database of systematic reviews, 2004, Oct-18, Issue:4

    Topics: Antiparkinson Agents; Benzophenones; Bromocriptine; Catechol O-Methyltransferase Inhibitors; Dopamine Agonists; Humans; Levodopa; Nitrophenols; Parkinson Disease; Pergolide; Tolcapone

2004
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
    Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:5

    Topics: Amantadine; Antiparkinson Agents; Apomorphine; Benzophenones; Benzothiazoles; Bromocriptine; Cabergoline; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dihydroergocryptine; Ergolines; Fetal Tissue Transplantation; Globus Pallidus; Humans; Indans; Indoles; Levodopa; Lisuride; Mesencephalon; Monoamine Oxidase Inhibitors; Neurosurgical Procedures; Nitrophenols; Parkinson Disease; Pergolide; Piribedil; Pramipexole; Selegiline; Thiazoles; Tolcapone

2005

Trials

3 trial(s) available for bromocriptine and tolcapone

ArticleYear
Tolcapone, bromocriptine, and Parkinson's disease. French Tolcapone Study Group.
    Lancet (London, England), 1997, Sep-06, Volume: 350, Issue:9079

    Topics: Antiparkinson Agents; Benzophenones; Bromocriptine; Drug Therapy, Combination; Drug Tolerance; Humans; Levodopa; Nitrophenols; Parkinson Disease; Tolcapone

1997
Efficacy and tolerability of tolcapone compared with bromocriptine in levodopa-treated parkinsonian patients. Tolcapone Study Group.
    Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:1

    Topics: Aged; Antiparkinson Agents; Benzophenones; Bromocriptine; Catechol O-Methyltransferase Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Nitrophenols; Parkinson Disease; Tolcapone; Treatment Outcome

1999
Effects of tolcapone and bromocriptine on cognitive stability and flexibility.
    Psychopharmacology, 2018, Volume: 235, Issue:4

    Topics: Adult; Attention; Bromocriptine; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Cognition; Dopamine Agonists; Double-Blind Method; Female; Humans; Male; Prefrontal Cortex; Reaction Time; Saccades; Tolcapone; Young Adult

2018

Other Studies

4 other study(ies) available for bromocriptine and tolcapone

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Species independence in brain tissue binding using brain homogenates.
    Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:7

    Topics: Animals; Brain; Dogs; Guinea Pigs; Humans; Macaca fascicularis; Mice; Rats; Species Specificity

2011
Effects of Dopaminergic Drugs on Cognitive Control Processes Vary by Genotype.
    Journal of cognitive neuroscience, 2020, Volume: 32, Issue:5

    Topics: Adult; Bromocriptine; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Cerebral Cortex; Corpus Striatum; Dopamine; Dopamine Agonists; Executive Function; Female; Humans; Male; Psychomotor Performance; Tolcapone; Young Adult

2020
Enhancing dopamine tone modulates global and local cortical perfusion as a function of COMT val158met genotype.
    NeuroImage, 2021, 11-15, Volume: 242

    Topics: Adult; Bromocriptine; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Corpus Striatum; Dopamine; Dopamine Agonists; Double-Blind Method; Executive Function; Female; Genotype; Humans; Male; Polymorphism, Single Nucleotide; Prefrontal Cortex; Tolcapone; Young Adult

2021